Case report reveals concurrent kaposi sarcoma and b-cell lymphoma in an HIV-negative patient, highlighting diagnostic challenges.
We report the case of a 70-year-old non-immunocompromised male patient with coexisting classic Kaposi sarcoma (KS) and stage IV B-cell lymphocytic lymphoma. KS had been evolving insidiously since 2017 but was only confirmed in 2024 following a retrospective histological re-review. The patient received two lines of systemic chemotherapy, rituximab plus bendamustine (R-BENDA) followed by paclitaxel, with transient clinical responses before disease progression. This case suggests that the intrinsic immune dysfunction associated with chronic lymphocytic leukemia (CLL) may provide a permissive environment for human herpesvirus 8 (HHV-8) reactivation in the absence of classically recognized immunodeficiency states (HIV infection, iatrogenic immunosuppression, or primary immunodeficiency) and underscores the importance of histological re-review of atypical or long-standing cutaneous lesions.
No takes yet. Share an insight, caveat, or question.
Ouahab et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: